Omega Funds
Overview
Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.
Investment Focus
- Strong management teams
- Innovative products
- Potential for significant impact in therapeutic areas
Portfolio Companies
Reach Omega Funds directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Omega Funds
What sectors does Omega Funds invest in?
Omega Funds invests in Healthcare, Life Sciences, Medical Devices, Biotechnology, Oncology and Precision Medicine, and is based in Boston, Massachusetts, United States. Omega Funds is listed as a vc in the ConnectSafely investor database.
What stage does Omega Funds invest at?
Omega Funds backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 10M - 50M.
Which regions does Omega Funds invest in?
Omega Funds invests across United States, United Kingdom, Germany, France, Italy and Denmark.
What companies has Omega Funds invested in?
Omega Funds's portfolio includes Beam Therapeutics, Bluebird Bio, Moderna, Alnylam Pharmaceuticals, Editas Medicine, Sarepta Therapeutics, Intellia Therapeutics and CRISPR Therapeutics.
How do I contact Omega Funds?
Omega Funds's contact details — including work email and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
